Weight Loss with FT218, a Once-Nightly Sodium Oxybate Formulation (ON-SXB), for the Treatment of Narcolepsy: Post Hoc Analysis from REST-ON

被引：0
|
作者：
Morse, Anne Marie [1 ]
Roy, Asim [2 ]
Dubow, Jordan [3 ]
Seiden, David [3 ]
Bogan, Richard [4 ,5 ]
机构：
[1] Janet Weis Childrens Hosp, Geisinger Med Ctr, Geisinger Commonwealth Sch Med, Danville, PA USA
[2] Ohio Sleep Med Inst, Dublin, OH USA
[3] Avadel Pharmaceut, Chesterfield, MO USA
[4] Univ South Carolina, Sch Med, Charleston, SC USA
[5] Med Univ SC, Charleston, SC USA
来源：
ANNALS OF NEUROLOGY | 2021年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
286
引用
收藏
页码：S242 / S242
页数：1
相关论文
共 50 条
  • [41] The Pharmacokinetics of Once-Nightly Sodium Oxybate FT218: Food Effect and Relative Biovailability Compared to Twice-Nightly Sodium Oxybate
    Seiden, David
    Grassot, Julien
    Monteith, David
    Dubow, Jordan
    NEUROLOGY, 2020, 94 (15)
  • [42] Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy
    Kushida, Clete A.
    Shapiro, Colin M.
    Roth, Thomas
    Thorpy, Michael J.
    Corser, Bruce C.
    Ajayi, Akinyemi O.
    Rosenberg, Russell
    Roy, Asim
    Seiden, David
    Dubow, Jordan
    Dauvilliers, Yves
    SLEEP, 2022, 45 (06)
  • [43] CATAPLEXY RESPONSE WITH ONCE-NIGHTLY SODIUM OXYBATE: POST HOC RESPONDER ANALYSIS FROM THE PHASE 3 REST-ON CLINICAL TRIAL
    Thorpy, M. J.
    Kushida, C. A.
    Ajayi, A. O.
    Dubow, J.
    Gudeman, J.
    SLEEP MEDICINE, 2024, 115 : 208 - 209
  • [44] EFFECTS OF ONCE-NIGHTLY SODIUM OXYBATE ON APNEA-HYPOPNEA INDEX: POST HOC ANALYSIS FROM THE PHASE 3 REST-ON CLINICAL TRIAL
    Stern, Thomas P.
    Ajayi, Akinyemi O.
    Bogan, Richard K.
    Corser, Bruce
    Abaluck, Brian
    Gudeman, Jennifer
    CHEST, 2024, 166 (04) : 6224A - 6226A
  • [45] COMPOSITE RESPONSE WITH ONCE-NIGHTLY SODIUM OXYBATE: SYMPTOM IMPROVEMENT IN PARTICIPANTS WITH NARCOLEPSY TYPE 1 IN REST-ON
    Ortiz, L. E.
    Roth, T.
    Morse, A. M.
    Thorpy, M. J.
    Harsh, J.
    Kushida, C. A.
    Dubow, J.
    Gudeman, J.
    Dauvilliers, Y.
    SLEEP MEDICINE, 2024, 115 : 210 - 211
  • [46] Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al.
    Skobieranda, Franck
    Candler, Shawn
    Macfadden, Wayne
    SLEEP, 2022, 45 (06)
  • [47] Efficacy of Once-Nightly Sodium Oxybate in Patients with Narcolepsy: Post Hoc Analyses of Sensitivity, Effect Size, and Numbers Needed to Treat from the Phase 3 REST-ON Trial
    Roth, Thomas
    Thorpy, Michael J.
    Kushida, Clete A.
    Gudeman, Jennifer
    CNS DRUGS, 2025, 39 (SUPPL1) : 61 - 70
  • [48] Response to: Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al.
    Kushida, Clete A.
    Roth, Thomas
    Shapiro, Colin M.
    Roy, Asim
    Rosenberg, Russell
    Ajayi, Akinyemi O.
    Seiden, David
    Gudeman, Jennifer
    SLEEP, 2022, 45 (06)
  • [49] IMPROVEMENT IN SLEEP LATENCY WITH ONCE-NIGHTLY SODIUM OXYBATE: ANALYSIS FROM THE PHASE 3 REST-ON CLINICAL TRIAL
    Thorpy, M. J.
    Shapiro, C. M.
    Kushida, C. A.
    Ohayon, M. M.
    Dubow, J.
    Gudeman, J.
    SLEEP MEDICINE, 2024, 115 : 218 - 218
  • [50] PHARMACOKINETICS AND DOSE PROPORTIONALITY OF FT218, AN INVESTIGATIONAL CONTROLLED RELEASE FORMULATION OF SODIUM OXYBATE FOR ONCE NIGHTLY DOSING
    Monteith, David
    Grassot, Julien
    Castellan, Charlotte
    Roth, Thomas
    SLEEP, 2019, 42
12345